IMNM Insider Transactions
71 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 1–71; provenance stays internal.
IMNM insiders transaction timeline
PurchaseSale
| Insider profile | Role | Date | Transaction | Shares | Price |
|---|---|---|---|---|---|
| Barchas Isaac | Director | 2026-08-12 | Sale | 11,048 | $27.25 |
| Barchas Isaac | Director | 2026-08-11 | Sale | 62,291 | $26.23 |
| Barchas Isaac | Director | 2026-08-10 | Sale | 10,125 | $26.07 |
| Barchas Isaac | Director | 2026-08-07 | Sale | 15,248 | $26.06 |
| Barchas Isaac | Director | 2026-08-06 | Sale | 20,840 | $26.06 |
| Horn Kinney | CHIEF BUSINESS OFFICER | 2026-08-04 | Sale | 90,616 | $25.09 |
| Horn Kinney | CHIEF BUSINESS OFFICER | 2026-07-07 | Sale | 1,092 | $25 |
| Barchas Isaac | Director | 2026-07-07 | Sale | 16,906 | $24.20 |
| Barchas Isaac | Director | 2026-07-06 | Sale | 83,094 | $24.11 |
| Lechleider Robert | Chief Medical Officer | 2026-07-02 | Sale | 16,072 | $23.44 |
| Lechleider Robert | Chief Medical Officer | 2026-07-02 | Sale | 16,214 | $22.76 |
| Lechleider Robert | Chief Medical Officer | 2026-07-02 | Sale | 22,714 | $21.95 |
| Barchas Isaac | Director | 2026-07-02 | Sale | 24,335 | $23.33 |
| Barchas Isaac | Director | 2026-07-02 | Sale | 75,665 | $22.35 |
| Barchas Isaac | Director | 2026-06-30 | Sale | 101,050 | $21.12 |
| Lechleider Robert | Chief Medical Officer | 2026-06-25 | Sale | 14,420.0 | $20.66 |
| Lechleider Robert | Chief Medical Officer | 2026-06-25 | Sale | 40,580.0 | $19.56 |
| Rosett Max | Chief Financial Officer | 2026-06-15 | Sale | 60,000.0 | $18.23 |
| BIENAIME JEAN JACQUES | Director | 2026-06-05 | Purchase | 1,000.0 | $19.27 |
| BIENAIME JEAN JACQUES | Director | 2026-06-05 | Purchase | 3,500.0 | $19.46 |
| BIENAIME JEAN JACQUES | Director | 2026-06-05 | Purchase | 6,000.0 | $19.48 |
| BIENAIME JEAN JACQUES | Director | 2026-06-05 | Sale | 10,000.0 | $19.41 |
| BIENAIME JEAN JACQUES | Director | 2026-06-05 | Sale | 500.0 | $19.44 |
| BIENAIME JEAN JACQUES | Director | 2026-05-15 | Purchase | 5,000.0 | $20.7 |
| Rosett Max | Chief Financial Officer | 2026-04-02 | Sale | 1,344.0 | $22.48 |
| Rosett Max | Chief Financial Officer | 2026-04-02 | Sale | 63,656.0 | $21.91 |
| Higgins Jack | Chief Scientific Officer | 2026-04-02 | Sale | 9,438.0 | $21.64 |
| SIEGALL CLAY B | President and CEO | 2026-03-27 | Purchase | 25,450.0 | $19.67 |
| WAGENHEIM PHILIP | Director | 2026-03-23 | Sale | 28,200.0 | $20.65 |
| WAGENHEIM PHILIP | Director | 2026-03-20 | Sale | 36,800.0 | $20.47 |
| BIENAIME JEAN JACQUES | Director | 2026-03-11 | Purchase | 1,000.0 | $21.55 |
| BIENAIME JEAN JACQUES | Director | 2026-03-10 | Purchase | 1,000.0 | $22.12 |
| SIEGALL CLAY B | President and CEO | 2025-12-30 | Purchase | 4,729.0 | $21.15 |
| Barchas Isaac | Director | 2025-12-22 | Sale | 11,251.0 | $22.34 |
| Barchas Isaac | Director | 2025-12-22 | Sale | 371,949.0 | $21.72 |
| Tsai Philip | Chief Technical Officer | 2025-12-19 | Purchase | 10,000.0 | $20.49 |
| SIEGALL CLAY B | President and CEO | 2025-12-19 | Purchase | 7,278.0 | $20.48 |
| SIEGALL CLAY B | President and CEO | 2025-12-18 | Purchase | 46,511.0 | $21.5 |
| BIENAIME JEAN JACQUES | Director | 2025-06-03 | Purchase | 5,000.0 | $9.38 |
| SIEGALL CLAY B | President and CEO | 2025-03-26 | Purchase | 137,100.0 | $7.29 |
| BIENAIME JEAN JACQUES | Director | 2025-03-25 | Purchase | 7,800.0 | $7.78 |
| BIENAIME JEAN JACQUES | Director | 2025-03-24 | Purchase | 7,000.0 | $8.21 |
| Tsai Philip | Chief Technology Officer | 2025-03-24 | Purchase | 12,300.0 | $8.42 |
| SIEGALL CLAY B | President and CEO | 2025-01-31 | Purchase | 150,000.0 | $7.75 |
| SIEGALL CLAY B | President and CEO | 2024-11-22 | Purchase | 33,943.0 | $9.78 |
| SIEGALL CLAY B | President and CEO | 2024-11-21 | Purchase | 66,057.0 | $9.54 |
| Lechleider Robert | Chief Medical Officer | 2024-11-21 | Purchase | 15,805.0 | $9.48 |
| Tsai Philip | Chief Technology Officer | 2024-11-21 | Purchase | 21,000.0 | $9.43 |
| Rosett Max | Chief Financial Officer | 2024-09-19 | Sale | 14,380.0 | $16.01 |
| BIENAIME JEAN JACQUES | Director | 2024-08-16 | Purchase | 7,000.0 | $13.94 |
| Higgins Jack | Chief Scientific Officer | 2024-08-15 | Sale | 3,524.0 | $13.93 |
| BIENAIME JEAN JACQUES | Director | 2024-05-21 | Purchase | 2,000.0 | $13.57 |
| SIEGALL CLAY B | President and CEO | 2024-05-21 | Purchase | 20,434.0 | $13.78 |
| SIEGALL CLAY B | President and CEO | 2024-05-20 | Purchase | 79,566.0 | $13.91 |
| SIEGALL CLAY B | President and CEO | 2023-10-02 | Purchase | 169,204.0 | $5.91 |
| Turner Bruce | Chief Strategy Officer | 2023-10-02 | Purchase | 42,300.0 | $5.91 |
| RAPP MICHAEL | Director | 2021-09-13 | Purchase | 25,962.0 | $19.96 |
| RAPP MICHAEL | Director | 2021-09-10 | Purchase | 15,500.0 | $17.85 |
| RAPP MICHAEL | Director | 2021-09-09 | Purchase | 22,280.0 | $18.46 |
| RAPP MICHAEL | Director | 2021-09-09 | Purchase | 8,170.0 | $17.44 |
| Lefenfeld Michael | Director | 2021-05-26 | Purchase | 1,335.0 | $19.03 |
| RAPP MICHAEL | Director | 2021-05-26 | Purchase | 2,300.0 | $18.94 |
| Lefenfeld Michael | Director | 2021-05-25 | Purchase | 2,715.0 | $18.44 |
| RAPP MICHAEL | Director | 2021-05-25 | Purchase | 19,303.0 | $18.32 |
| Sarma Purnanand D | President and CEO | 2021-05-25 | Purchase | 10,500.0 | $18.41 |
| Lefenfeld Michael | Director | 2021-05-24 | Purchase | 600.0 | $17.8 |
| RAPP MICHAEL | Director | 2021-05-24 | Purchase | 31,895.0 | $18.38 |
| WAGENHEIM PHILIP | Director | 2021-05-24 | Purchase | 13,500.0 | $18.35 |
| LAMATTINA JOHN L | Director | 2021-05-24 | Purchase | 5,102.0 | $18.58 |
| LAMATTINA JOHN L | Director | 2021-05-24 | Purchase | 338.0 | $18.44 |
| RAPP MICHAEL | Director | 2020-10-06 | Purchase | 83,332.0 | $12.0 |